Oxford Nanopore Technologies plc ONTTF
Set alert
At close · Oct 30
- YTD
- +71.40%
- 1 year
- +56.81%
- Open
- 3.12
- Prev close
- 3.11
- Mkt cap
- 2.88B
- Vol
- 2.96K
- Avg vol
- 50.46K
- EPS
- -0.17
- P/E
- 0.00
More statistics
- Low
- 3.03
- High
- 3.12
- Earnings
- Aug 19, 2026
News
1 month ago proactiveinvestors.com
IP Group banks £21m in Oxford Nanopore divestment
IP Group PLC (LSE:IPO) told investors it has banked around £21 million from a partial sale of its stake in Oxford Nanopore Technologies PLC (LSE:ONT) while retaining a holding worth more than £150…
1 month ago proactiveinvestors.com
Oxford Nanopore target price raised by RBC on AI opportunity
RBC Capital Markets raised its target price for Oxford Nanopore Technologies PLC (LSE:ONT) to 300p from 225p, saying the sequencing company is well placed to benefit from growing demand for…
1 month ago seekingalpha.com
Oxford Nanopore Technologies plc (OXFYY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Oxford Nanopore Technologies plc (OXFYY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
2 months ago proactiveinvestors.co.uk
Oxford Nanopore target price hiked to 196p by Panmure Liberum on strategic pivot
Oxford Nanopore Technologies PLC (LSE:ONT) secured an upgrade to a 'buy' rating from Panmure Liberum on Monday, as analysts cheered a lucrative diagnostics deal despite lingering strategic risks. The…
2 months ago seekingalpha.com
Oxford Nanopore Technologies plc (OXFYY) Q2 2026 Earnings Call Transcript
Oxford Nanopore Technologies plc (OXFYY) Q2 2026 Earnings Call Transcript
2 months ago marketbeat.com
Oxford Nanopore Technologies H1 Earnings Call Highlights
Oxford Nanopore Technologies LON: ONT reported first-half revenue growth below its expectations as declines in China, the Middle East and delayed orders in the Americas weighed on performance, while…
2 months ago proactiveinvestors.co.uk
Oxford Nanopore sets $700m revenue target for 2030
Oxford Nanopore Technologies PLC (LSE:ONT), the DNA-sequencing technology company, has set a target of more than $700 million in annual revenue by 2030 as it maps out a path to profitability. The…
3 months ago proactiveinvestors.co.uk
Oxford Nanopore shares slide 16% after first-half sales miss expectations
Shares in Oxford Nanopore Technologies PLC (LSE:ONT) fell 16% to 101.2 pence after the company said first-half trading had come in below management expectations. The maker of nanopore-based…
5 months ago proactiveinvestors.co.uk
Leading banks back Oxford Nanopore after London Calling showcases maturing platform
Oxford Nanopore Technologies PLC (LSE:ONT), the LSE-listed DNA sequencing company, has drawn positive reviews from RBC Capital Markets and Citi following its annual London Calling customer conference…
7 months ago businesswire.com
Oxford Nanopore and A.D.A.M. Innovations Announce International Collaboration to Accelerate Advanced Genomic Medicine in Japan
OXFORD, England & TOKYO--(BUSINESS WIRE)-- #Nanopore--Oxford Nanopore Technologies, the company delivering a new generation of molecular sensing technology based on nanopores, and A.D.A.M.…
7 months ago seekingalpha.com
Oxford Nanopore Technologies plc (ONTTF) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Oxford Nanopore Technologies plc (ONTTF) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
7 months ago businesswire.com
ViruSure Launches First GMP-Validated Viral Safety Test Based on Oxford Nanopore Sequencing
OXFORD, England & VIENNA--(BUSINESS WIRE)-- #Nanopore--ViruSure, an Asahi Kasei company and global leader in pathogen safety testing for biopharmaceuticals, today announced the launch of the world's…
8 months ago proactiveinvestors.co.uk
Citi keeps 'buy' rating on Oxford Nanopore as profitability target holds despite revenue miss
Oxford Nanopore Technologies PLC (LSE:ONT), the DNA sequencing company, retained its 'buy' rating at Citi after reporting second-half 2025 adjusted earnings ahead of expectations, even as it issued…
8 months ago seekingalpha.com
Oxford Nanopore Technologies plc (ONTTF) Q4 2025 Earnings Call Transcript
Oxford Nanopore Technologies plc (ONTTF) Q4 2025 Earnings Call Transcript
9 months ago seekingalpha.com
Oxford Nanopore Technologies plc (ONTTF) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Oxford Nanopore Technologies plc (ONTTF) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
9 months ago proactiveinvestors.co.uk
Oxford Nanopore rises on strong 2025 revenue growth
Shares in Oxford Nanopore Technologies PLC (LSE:ONT) rose 8% to 152p on Monday after the DNA sequencing group said its revenue for 2025 would come in slightly ahead of guidance, helped by…
9 months ago businesswire.com
Oxford Nanopore Receives Regulatory Approval for its First Diagnostic Device in the UK and Europe
OXFORD, England--(BUSINESS WIRE)-- #Nanopore--Oxford Nanopore Technologies today announces that the GridION™ Dx is now both CE and UKCA marked, making it the company's first IVD device registered in…
11 months ago seekingalpha.com
Oxford Nanopore Technologies plc (ONTTF) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Oxford Nanopore Technologies plc (ONTTF) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
1 year ago businesswire.com
Oxford Nanopore Announces PromethION Plus Flow Cell and Human Genetics Updates at ASHG 2025
OXFORD, England--(BUSINESS WIRE)-- #Nanopore--At the American Society of Human Genetics (ASHG) 2025 industry session on 16th October, Oxford Nanopore Technologies will share its latest developments…
1 year ago prnewswire.com
Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032
Grants Bio-Techne expanded commercial rights to develop a portfolio of genetics products beyond the recently launched AmplideX® Nanopore Carrier Plus Kit Establishes a framework to define and propose…